- Home
- CLOV vs CLVT Comparison
CLOV vs CLVT Comparison
Compare CLOV & CLVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLOV | CLVT |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | 12000 |
| Industry | Medical Specialities | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLOV | CLVT |
|---|---|---|
| Price | $4.69 | $2.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 7 |
| Target Price | $2.90 | ★ $3.22 |
| AVG Volume (30 Days) | 8.9M | ★ 9.7M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.03 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $1,924,308,000.00 | N/A |
| Revenue This Year | $52.59 | N/A |
| Revenue Next Year | $15.37 | $2.12 |
| P/E Ratio | $93.20 | ★ N/A |
| Revenue Growth | ★ 40.34 | N/A |
| 52 Week Low | $1.58 | $1.66 |
| 52 Week High | $5.59 | $4.77 |
Technical Indicators
Market Signals| Indicator | CLOV | CLVT |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | 45.54 |
| Support Level | $1.96 | $1.90 |
| Resistance Level | $5.18 | $2.72 |
| Average True Range (ATR) | 0.28 | 0.18 |
| MACD | -0.12 | 0.03 |
| Stochastic Oscillator | 5.73 | 36.81 |
Price Performance
Historical ComparisonAbout CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas, while Europe, Middle East, and Africa account for around a quarter.